In this study, our results indicated that TCO inhibits cell proliferation and EMT in lung cancer cells by downregulation of Trop2, demonstrating the therapeutic potential of TCO for lung cancer treatment. This evidence concerns the gene TACSTD2 and lung carcinoma.